- ￥2600 - 5350
- Solarbio|ActivAb
- 北京
- K010666M
- 2025年08月22日
- FCM
- Mouse
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG2a，κ
- 保存条件：
Store at 4℃ in dark.Do not freeze.
- 克隆性：
Monoclonal Antibody
- 标记物：
Biotin，Cy3，Cy3.5，Cy5，Cy5.5，Cy7，FITC，HRP，RBITC，Solar Fluor 350，Solar Fluor 405，Solar Fluor 488，Solar Fluor 532，Solar Fluor 555，Solar Fluor 568，Solar Fluor 594，Solar Fluor 633，Solar Fluor 640，Solar Fluor 647，Solar Fluor 660，Solar Fluor 680，Solar Fluor 750
- 适应物种：
Human
- 目录编号：
170482
- 级别：
实验级别
- 库存：
现询
- 供应商：
北京索莱宝科技有限公司
- 宿主：
Mouse
- 应用范围：
FCM
- 浓度：
FCM 5uL/Test.
- 靶点：
CD303
- 抗体英文名：
Anti-CD303(APC) Monoclonal Antibody
- 抗体名：
BDCA 2，BDCA2，Blood dendritic cell antigen 2，CD303，CLEC4C，CLECSF11，CLECSF7，Dendritic lectin，DLEC，HECL，PRO34150
- 规格：
25T/100T
| 规格： | 25T | 产品价格： | ￥2600.0 |
|---|---|---|---|
| 规格： | 100T | 产品价格： | ￥5350.0 |
| 基本信息 | |
| 英文名称 | Anti-CD303(APC) Monoclonal Antibody |
| 宿主 | Mouse |
| 克隆类型 | Monoclonal Antibody |
| 亚型 | IgG2a，κ |
| 交叉反应 | Human |
| 应用 | FCM |
| 稀释比例 | FCM 5uL/Test. |
| 密度 | |
| 靶标 | CD303 |
| 别名 | BDCA 2，BDCA2，Blood dendritic cell antigen 2，CD303，CLEC4C，CLECSF11，CLECSF7，Dendritic lectin，DLEC，HECL，PRO34150 |
| 背景说明 | This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions，such as cell adhesion，cell-cell signalling，glycoprotein turnover，and roles in inflammation and immune response. The encoded type 2 transmembrane protein may play a role in dendritic cell function. Two transcript variants encoding distinct isoforms have been identified for this gene. |
| Swiss Prot | Q8WTT0 |
| Gene ID | 170482 |
| 亚细胞定位 | Cell membrane |
| 理论分子量 | 21/25kDa |
| 储存条件 | Store at 4℃ in dark.Do not freeze. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The Application of Monoclonal Antibodies in the Treatment of Lymphoma
lymphoma treated with a chimeric anti-CD20 mAb, and Maloney and co-workers (2 ) recently reported a 50% response rate in relapsed, low-grade, NHL, with a 10---11 mo duration. Encouragingly, patients in these studies did not raise antibody responses
monoclonal antibodies have improved responses with minimal toxicities. For instance, Rituximab (chimeric anti-CD20 monoclonal antibody) was the first FDA-approved monoclonal antibody for the treatment of patients with non-Hodgkin’s lymphoma (NHL
Polyclonal and Monoclonal Antibodies
later again (2 + 2 week cycle). Monoclonal Antibody If titre is positive do one of the following 2 weeks later: I - Boost tail vein with 20 ug- 50 ug of Antigen in PBS and proceed with fusion on day 4. OR II - Boost
技术资料暂无技术资料 索取技术资料
